SOLICITATION NOTICE
A -- Vaccine and Treatment Evaluation Units (VTEUs): Evaluation of Control Measures Against Diseases Other Than AIDS
- Notice Date
- 5/15/2006
- Notice Type
- Solicitation Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions 6700 B Rockledge Room 3214 MSC7612, Bethesda, MD, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- NIH-NIAID-DMID-08-03
- Response Due
- 12/15/2006
- Point of Contact
- Teresa Baughman, Contract Specialist, Phone 301-451-3690, Fax 301-480-4675,
- E-Mail Address
-
tb14j@nih.gov
- Description
- The Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), has a requirement to evaluate vaccine and therapeutic candidates in Phase 1 through Phase 4 clinical trials, as well as to conduct other types of evaluations and analyses, for viral (other than HIV), bacterial, parasitic and fungal pathogens, including NIAID priority biodefense pathogens (http://www3.niaid.nih.gov/Biodefense/bandc_priority.htm). The scope of investigational vaccine and therapeutic candidates includes live, attenuated, killed, vectored DNA and combination vaccines, adjuvants, novel therapeutic agents such as immunomodulatory agents, and approaches to vaccine or therapeutic delivery, dose finding, schedule, routes and modes of delivery. The Contractor shall incorporate novel vaccine and therapeutic technologies as they are developed into clinical trials. Clinical research will be carried out in the general population, including pediatric, adult and elderly subjects, as well as additional populations, when necessary, such as women of reproductive age, pregnant women, immunocompromised populations, non-U.S. populations, and populations with underlying medical conditions. Contractors shall be experienced clinical research sites with access to general and additional study populations and the capacity to provide research facilities, services and personnel to carry out the full range of clinical research activities. These activities require outpatient and inpatient clinical research facilities, clinical and research laboratory facilities, research pharmacy facilities, and other general, non-clinical facilities. Scientific and technical staff shall have expertise, training and experience in the conduct and oversight of clinical trials and clinical studies in infectious diseases in accordance with Good Clinical Practices and applicable Federal regulations governing research involving human subjects. It is anticipated that up to eight (8) cost reimbursement, completion type contracts will be awarded for a 7-year period of performance beginning on or about November 1st, 2007. This RFP will be available on or about June 2, 2006, and may be accessed through the FedBizOpps and the NIAID Office of Acquisitions (OA) Home Page at http://www.niaid.nih.gov/contract/rfps.htm. All responsible sources may submit a proposal which shall be considered by the agency. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile transmissions will be accepted. See Government-wide Numbered Note 26. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (15-MAY-2006); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link to FedBizOpps document.
(http://www.fbo.gov/spg/HHS/NIH/NIAID/NIH-NIAID-DMID-08-03/listing.html)
- Record
- SN01048590-F 20060517/060515221358 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |